VANCOUVER, British Columbia, September 1, 2020 (GLOBE NEWSWIRE) – Global Care Capital Inc. (CSE: HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment firm participating in an investment entry-level opportunities in public and personal companies, is pleased to announce that its corporate holding company, ViraxClear, through its joint venture, Shanghai Biotechnology Devices Ltd. (“SBD”) has signed a non-binding letter of intent with Blue Med (Pty ) Ltd. on August 27, 2020 (“Blue Med”) for the distribution of up to five million COVID-19 Immediate Antibody Control Kits (“Verification Kits”) for the South African market, a contract valued at $ 2 five million in gross income. The kits will be provided through ViraxClear’s previously announced vendor, Shanghai Liangrun Biomedicine Technology Co., Ltd (“SLB”).
You can get a photo that accompanies this ad in https://www.globenewswire.com/NewsRoom/AttachmentNg/522a2204-291b-4035-9e35-a6ff4129f8b3
James Foster, CEO of Virax Clear, said: “This represents an important step forward for ViraxClear in terms of our global ambitions within the company.We are pleased to incorporate such a strategic distribution region into our portfolio, especially given the scale of operations Blue Med is to meet.
The letter of intent provides a 90-day exclusivity era in which ViraxClear and Blue Med intend to signal a final deal with a total contract price of up to $2 five million for five million check kits.
The South African Health Products Regulatory Authority (SAHPRA) has approved its distribution in South Africa.
Blue Med is a diversified construction, genuine urbanization, medical generation distribution and control organization that was established in 2007 and has its main workplace in Randburg, South Africa.
About ViraxClear
Website:
https://www.viraxcare.com
Global Care Capital is a global investment firm that specializes in providing initial financing to public and personal companies.The company engages in new initial investment opportunities in underdeveloped assets of the past and secures positions in initial investment opportunities that adequately reflect the threat profile..
Website:
www.globalcarecapital.com
GLOBAL CARE CAPITAL CORP.:
Alex Somjen, President and CEO
604-687-2038
Neither CSE nor its regulatory provider accepts a duty of adequacy or accuracy of this release.
Forward-looking information: This press release includes secure statements that would possibly be considered “forward-looking statements.”The use of one of the words “anticipate”, “continue”, “estimate”, “wait”, “would possibly, “”want”, “want “,” project “,” deserve “,” believe “and similar expressions are intended to identify forward-looking statements.While the Company believes that the expectations and assumptions on which forward-looking statements are based are reasonable, forward-looking statements deserve that they are not unduly trusted, as the Company cannot provide any assurance that they will be accurate.By their very nature, they involve inherent threats and insecurities. These statements are valid only as of the date of this press release.Actual effects may differ materially from those expected lately due to a number of points and threats, adding diminating threat points mentioned in the Company’s disclosure documents that are under the Company’s profile in www.sedar.com